Members of the Chinese public continue to report more severe cases and sudden deaths in the country despite the regime’s cover up.
The ruling Chinese Communist Party’s (CCP) health authorities recently reported that KP.2, the dominant COVID-19 strain currently spreading around the world, has been mutating in China.
Meanwhile, members of the Chinese public across the country revealed to the Chinese-language edition of The Epoch Times that local COVID-19 outbreak situations were serious and that authorities were still concealing information about COVID’s toll.
On May 14, the Chinese regime’s Center for Disease Control and Prevention (CDC) issued a notice stating that the KP.2 variant was detected for the first time in local cases in Guangdong on March 11. According to the state, as of May 12, a total of 25 KP.2 sequences have been reported across China.
However, the CCP health authorities claimed that the proportion of KP.2 is at an extremely low level, and at present, the top three mutant strains in China are JN.1, JN.1.16, and JN.1.4.
Since January, KP.2 has accounted for an increasing percentage of cases globally. On May 3, the World Health Organization listed KP.2 as a COVID-19 variant “under monitoring.”
On May 13, Zhao Wei, director of the Biosafety Research Center at China’s Southern Medical University, told Chinese state media that the emergence of new mutant strains of COVID-19 shows that the virus has not disappeared in China.
The CCP suspended all COVID-19 testing in hospitals when it suddenly abandoned its draconian “zero-COVID” policy and control measures in December 2022, which was followed by a massive wave of infections and countless deaths across the country.
The Chinese regime has attributed the waves of respiratory infections resembling COVID-19 symptoms in China to various pathogens and other causes, such as mycoplasma pneumonia, influenza A, and influenza B while deliberately avoiding any mention of COVID-19.
KP.2 (also known as FLiRT) is an Omicron JN.1-derived variant that has independently evolved three additional mutations in the spike protein that health experts say could increase the virus’s transmissibility and ability to evade existing antibodies from previous infection or vaccines. It was first reported in India on Jan. 2.
By Alex Wu
